| Issue |
Title |
File |
| Vol 21, No 2 (2026) |
Experience with pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria and suboptimal response to C5 inhibitor therapy |
(Rus)
|
|
Finyakina M.N., Nikulina O.F., Galtseva I.V., Mulina I.I., Ochirova Z.A., Savintseva M.N., Lukina E.A.
|
| Vol 21, No 2 (2026) |
Minimal residual disease monitoring using multicolor flow cytometry and allele-specific polymerase chain reaction for the MYD88 gene p.L265P mutation in patients with Waldenstrom’s macroglobulinemia |
(Rus)
|
|
Galtseva I.V., Vinnikova A.B., Grachev A.E., Kulikov A.A., Tsoy Y.A., Nikiforova K.A., Kapranov N.M., Kulikov S.M., Starchenko S.E., Severina N.A., Nikulina E.E., Sudarikov A.B., Gribanova E.O., Zvonkov E.E., Troitskaya V.V., Parovichnikova E.N.
|
| Vol 21, No 2 (2026) |
Efficacy of avatrombopag in patients with immune thrombocytopenia |
(Rus)
|
|
Zakharov S.G., Mitina T.A., Zakharova A.V., Demakova N.A., Chernykh Y.B., Belousov K.A., Vysotskaya L.L., Trifonova E.V.
|
| Vol 21, No 2 (2026) |
Diagnostic features and treatment approaches for AL amyloidosis: a literature review and clinical case report |
(Rus)
|
|
Ryabukhina Y.E., Zeynalova P.A., Akhobekov A.A., Abbasbeyli F.M., Ivanova Z.Z., Davydov M.M.
|
| Vol 20, No 2 (2025) |
Monomorphic type of maculopapular cutaneous mastocytosis: rationale for interdisciplinary collaboration |
(Rus)
|
|
Kasikhina E.I., Potekaev N.N., Zhukova O.V., Ostretsova M.N.
|
| Vol 20, No 2 (2025) |
Genetic features of indolent and advanced forms of systemic mastocytosis |
(Rus)
|
|
Shikhbabaeva D.I., Vinogradova O.Y., Kobzev Y.N., Neverova A.L., Malakho S.G., Molitvina M.A., Pankrashkina M.M., Chernikov M.V., Ptushkin V.V.
|
| Vol 20, No 2 (2025) |
Results of asciminib therapy as part of managed access program in patients with chronic myeloid leukemia with T315I mutation |
(Rus)
|
|
Petrova A.N., Lomaia E.G., Morozova E.V., Shukhov O.A., Chelysheva E.Y., Vlasova Y.Y., Kuzmina E.A., Kulemina O.V., Nemchenko I.S., Bykova A.V., Sudarikov A.B., Kokhno A.V., Turkina A.G.
|
| Vol 20, No 1 (2025) |
The phenomenon of clonal hematopoiesis: etiology, classification and its prognostic role |
(Rus)
|
|
Kunevich E.O., Mikhaleva M.A., Krysyuk O.B., Bogdanov A.N., Zhernyakova A.A., Voloshin S.V.
|
| Vol 20, No 1 (2025) |
Targeted therapy of newly diagnosed FLT3-mutated acute myeloid leukemia. A single-center ambispective cohort study |
(Rus)
|
|
Pastukhov N.K., Bondarenko S.N., Smirnova A.G., Vlasova Y.Y., Zhogolev D.K., Ayubova B.I., Smykova O.G., Volkov N.P., Moiseev I.S., Kulagin A.D.
|
| Vol 20, No 1 (2025) |
Diffusion-weighted magnetic resonance imaging as an alternative to positron emission tomography combined with computed tomography with 18F-fluorodeoxyglucose in patients with lymphomas: a literature review and clinical observations |
(Rus)
|
|
Alekseev S.A., Troyan V.N., Rukavitsyn O.A., Trefilov A.A.
|
| Vol 20, No 1 (2025) |
Ocular involvement in pediatric patients with acute leukemia relapse: points of diagnosis and treatment |
(Rus)
|
|
Radzhabova G.A., Mashchyts V.D., Naumenko L.V., Valiev T.T.
|
| Vol 19, No 4 (2024) |
Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results) |
(Rus)
|
|
Mingalimov M.A., Baryakh E.A., Misyurin A.V., Kesaeva L.A., Mkrtchyan A.S., Misyurina E.N., Tolstykh T.N., Orlova M.S., Akhmadeeva A.A., Chudnova T.S., Ivanova D.D., Kochneva O.L., Zotina E.N., Makeshova A.B., Andreev S.S., Yatskov K.V., Samsonova I.V., Lysenko M.A.
|
| Vol 19, No 4 (2024) |
Evolution of therapeutic approaches in patients with chronic myeloid leukemia and T315I mutation |
(Rus)
|
|
Turkina A.G., Lomaia E.G., Morozova E.V., Vinogradova O.Y., Mitina T.A., Shatokhin Y.V., Ovsyannikova E.G., Vlasova Y.Y., Kulikov S.M., Chelysheva E.Y.
|
| Vol 19, No 4 (2024) |
Clinical and prognostic significance of T-regulatory cells and CD28 expression on T-lymphocytes in patients with immune thrombocytopenia |
(Rus)
|
|
Chuksina Y.Y., Zakharov S.G., Mitina T.A., Khmelevskaya A.N.
|
| Vol 19, No 4 (2024) |
Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review |
(Rus)
|
|
Ivanova D.D., Baryakh E.A., Mingalimov M.A., Misyurina E.N., Polyakov D.S., Savosina N.A., Beregov M.M., Donskoy M.A., Makeshova A.B., Tolstykh T.N., Kochneva O.L., Kravchuk T.S., Zhelnova E.I., Yatskov K.V., Mnoyan A.K., Grashchenko I.M., Shevchenko N.A., Vinokurov A.A., Samsonova I.V., Lysenko M.A.
|
| Vol 19, No 4 (2024) |
Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia |
(Rus)
|
|
Galtseva I.V., Parovichnikova E.N., Davydova Y.O., Kapranov N.M., Nikiforova K.A., Chabaeva Y.A., Kuzmina L.A., Konova Z.V., Kastrikina I.S., Aleshina O.A., Lukianova I.A., Troitskaya V.V., Gaponova T.V., Kulikov S.M.
|
| Vol 19, No 3 (2024) |
Autologous stem cell transplantation in newly diagnosed multiple myeloma patients with severe renal failure requiring hemodialysis. A single-center experience |
(Rus)
|
|
Kliuchagina Y.I., Zeynalova P.A., Gromova E.G., Valiev T.T.
|
| Vol 19, No 3 (2024) |
Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study |
(Rus)
|
|
Vinogradova O.Y., Pankraskina M.M., Neverova A.L., Shikhbabaeva D.I., Murzabekova M.A., Chernikov M.V., Popova A.V., Kosenkova V.P., Egoryan L.B., Ptushkin V.V.
|
| Vol 19, No 3 (2024) |
Immune thrombocytopenia: literature review |
(Rus)
|
|
Zakharov S.G.
|
| Vol 19, No 3 (2024) |
Retrospective analysis of own long-term experience in studying the BCR::ABL kinase domain mutational status in patients with chronic myeloid leukemia |
(Rus)
|
|
Kustova D.V., Motyko E.V., Kirienko A.N., Gert T.N., Leppyanen I.V., Bakay M.P., Efremova E.V., Morozova E.V., Lomaia E.G., Shuvaev V.A., Sidorkevich S.V., Martynkevich I.S.
|
| Vol 19, No 3 (2024) |
Influence of baseline telomere length on the results of immunosuppressive therapy in aplastic anemia patients |
(Rus)
|
|
Luchkin A.V., Mikhailova E.A., Galtseva I.V., Fidarova Z.T., Abramova A.V., Davydova Y.O., Kapranov N.M., Nikiforova K.A., Tsoy Y.A., Kulikov S.M., Parovichnikova E.N.
|
| Vol 19, No 3 (2024) |
Complement C3 inhibitor in patients with paroxysmal nocturnal hemoglobinuria with suboptimal response to C5 inhibitor therapy |
(Rus)
|
|
Marchenko M.V., Klimova O.U., Anikina E.V., Lapina A.V., Rudakova T.A., Ksenzova T.I., Kulagin A.D.
|
| Vol 19, No 3 (2024) |
Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice |
(Rus)
|
|
Dmitrieva E.A., Voloshin S.V., Kaplanov K.D., Touliet V., Zasypkina V.V., Magdych O.V., Klinushkina E.F.
|
| Vol 19, No 3 (2024) |
Immunological features of the bone marrow microenvironment and assessment of bone marrow lesions in patients with classical Hodgkin lymphoma |
(Rus)
|
|
Melnikova A.A., Abbasbeyli F.M., Mushkarina T.Y., Vernyuk M.A., Zeynalova P.A., Grivtsova L.Y., Ivanov S.A., Kaprin A.D.
|
| Vol 19, No 3 (2024) |
Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry |
(Rus)
|
|
Tolstykh T.N., Misyurina E.N., Mingalimov M.A., Baryakh E.A., Zhelnova E.I., Gagloeva D.E., Kardovskaya S.A., Chudnova T.S., Zotina E.N., Ivanova D.D., Kochneva O.L., Yatskov K.V., Shimanovskaya L.T., Mar’in D.S., Makeshova A.B., Chernova N.G., Dudina G.A., Granatkin M.A., Semina T.A., Misyurin A.V., Lysenko M.A.
|
| Vol 19, No 2 (2024) |
Cladribine chemotherapy of multifocal, multisystemic form of Rosai–Dorfman disease: literature review and case report |
(Rus)
|
|
Potapenko V.G., Abramov D.S., Baykov V.V., Grigorieva T.L., Selinkina M.S., Nikolskaya L.O., Emile J.
|
| Vol 19, No 2 (2024) |
Immunophenotyping of blood and bone marrow cells as a way to search for differentiation syndrome risk factors in acute promyelocytic leukemia |
(Rus)
|
|
Semenova A.A., Galtseva I.V., Troitskaya V.V., Kapranov N.M., Davydova Y.O., Nikiforova K.A., Loseva A.G., Ermolaev A.A., Surimova V.A., Kulikov S.M., Parovichnikova E.N.
|
| Vol 19, No 2 (2024) |
Objectification of the method for glomerular filtration rate assessing in patients with diffuse large B-cell lymphoma during induction immunochemotherapy |
(Rus)
|
|
Nozdricheva A.S., Lysenko I.B., Guskova N.K., Nikolaeva N.V., Gaysultanova Y.S., Dimitriadi S.N., Ishonina O.G.
|
| Vol 19, No 2 (2024) |
Significance of immunophenotypic, cytogenetic, and molecular markers in adult patients with T-cell lymphoblastic leukemia |
(Rus)
|
|
Vasileva A.N., Aleshina O.A., Kotova E.S., Biderman B.V., Obukhova T.N., Galtseva I.V., Dvirnyk V.N., Zakharko E.I., Sudarikov A.B., Parovichnikova E.N.
|
| Vol 19, No 2 (2024) |
Genetic polymorphisms as predictors of methotrexate toxicity: literature review |
(Rus)
|
|
Radzhabova G.A., Valiev T.T., Ryabukhina Y.E., Savelyeva M.I., Abdullaev S.P., Gurieva O.D., Zeynalova P.A.
|
| Vol 19, No 2 (2024) |
VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia |
(Rus)
|
|
Zakharko E.I., Dvirnyk V.N., Chabaeva Y.A., Drokova D.G., Rybkina E.B., Lavrishinets K.A., Bulgakov A.V., Panasenko M.N., Fidarova Z.T., Lukianova I.A., Aleshina O.A., Kulikov S.M., Gaponova T.V., Troitskaya V.V., Parovichnikova E.N.
|
| Vol 18, No 4 (2023) |
Diagnostic and therapeutical approaches to H3K27M-altered diffuse midline glioma in children: a review |
(Rus)
|
|
Morgacheva D.A., Sitovskaia D.A., Dinikina Y.V.
|
| Vol 18, No 4 (2023) |
Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study |
(Rus)
|
|
Vinogradova O.Y., Shikhbabaeva D.I., Kobzev Y.N., Neverova A.L., Pankraskina M.M., Malakho S.G., Chernikov M.V., Murzabekova M.A., Popova A.G., Egoryan L.B., Krechetova A.V., Ptushkin V.V.
|
| Vol 18, No 4 (2023) |
Diagnostic and therapeutic approaches for lymphoblastic lymphomas from progenitor cells in children and adolescents |
(Rus)
|
|
Pavlova T.Y., Valiev T.T.
|
| Vol 18, No 4 (2023) |
Diagnostic potential of plasma CD30(+) small extracellular vesicles in Hodgkin lymphoma |
(Rus)
|
|
Katsuba K.E., Kramynin L.A., Slyusarenko M.A., Shalaev A.V., Sharoyko V.V., Valitova A.A., Artem’eva A.S., Krzhivitskiy P.I., Filatova L.V., Malek A.V.
|
| Vol 18, No 2 (2023) |
Significance of bone marrow immunohistochemical analysis in patients with plasma cell neoplasms |
(Rus)
|
|
Kozich Z.M., Martinkov V.N., Zhandarov M.Y., Pugacheva Z.N., Klimkovich N.N.
|
| Vol 18, No 2 (2023) |
Autoimmune hemolytic anemia: the current state of the issue |
(Rus)
|
|
Vasilchenkova P.I., Galtseva I.V., Lukina E.A.
|
| Vol 18, No 2 (2023) |
Comparison of cytokine secretion and study of their effect on erythropoiesis in patients with malignant neoplasms with anemia of chronic disease, iron deficiency anemia, and their combination |
(Rus)
|
|
Sakhin V.T., Kryukov E.V., Kazakov S.P., Sotnikov A.V., Gordienko A.V., Zavartsev M.A., Rukavitsyn O.A.
|
| Vol 18, No 1 (2023) |
Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study |
(Rus)
|
|
Cherepanova V.V., Kurysheva M.A., Odintsova S.V.
|
| Vol 18, No 1 (2023) |
Clinical features of multiple myeloma with bone plasmacytomas |
(Rus)
|
|
Mamaeva E.A., Soloveva M.V., Solovev M.V., Kovrigina A.M., Danilina T.P., Mendeleeva L.P.
|
| Vol 17, No 4 (2022) |
First experience of total body irradiation in conditioning regimes for allogenic hematopoietic stem cells transplantation in children with acute lymphoblastic leukemia in Saint Petersburg |
(Rus)
|
|
Dinikina Y.V., Mikhailov A.V., Rusina M.A., Smirnova A.Y., Vorob’ov N.A., Kataev N.A., Kubasov A.V.
|
| Vol 17, No 4 (2022) |
Possibilities of targeted therapy for myelofibrosis: Moscow experience |
(Rus)
|
|
Vinogradova O.Y., Pankrashkina M.M., Shikhbabaeva D.I., Chernikov M.V., Neverova A.L., Ivanova V.L., Nikitin E.A., Usikova E.V., Ptushkin V.V.
|
| Vol 17, No 4 (2022) |
New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome |
(Rus)
|
|
Morozova E.V., Tsvetkov N.Y., Barabanshchikova M.V., Yurovskaya K.S., Moiseev I.S.
|
| Vol 17, No 4 (2022) |
Comparison of fragment analysis and PCR electrophoresis methods for the detection of FLT3‑ITD mutations in patients with acute myeloid leukemia |
(Rus)
|
|
Maslyukova I.E., Kurochkin D.V., Martynova E.V., Bakhtina V.I., Subbotina T.N.
|
| 1 - 44 of 44 Items |
|
